The chemokine CXCL9 exacerbates chemotherapy-induced acute intestinal damage through inhibition of mucosal restitution (Q38940305)

7 September 2017

title

The chemokine CXCL9 exacerbates chemotherapy-induced acute intestinal damage through inhibition of mucosal restitution (English)

1 reference

7 September 2017

Huili Lu

1

1 reference

7 September 2017

Hongyu Liu

2

1 reference

7 September 2017

Jiaxian Wang

3

1 reference

7 September 2017

Jiaqing Shen

4

1 reference

7 September 2017

Shunyan Weng

5

1 reference

7 September 2017

Lei Han

6

1 reference

7 September 2017

Tao Sun

7

1 reference

7 September 2017

Lan Qian

8

1 reference

7 September 2017

Mingyuan Wu

9

1 reference

7 September 2017

Shunying Zhu

10

1 reference

7 September 2017

Yan Yu

11

1 reference

7 September 2017

Wei Han

12

1 reference

7 September 2017

Jianwei Zhu

13

1 reference

7 September 2017

Anja Moldenhauer

14

1 reference

7 September 2017

publication date

15 November 2014

1 reference

Journal of Cancer Research and Clinical Oncology

7 September 2017

published in

1 reference

7 September 2017

volume

141

1 reference

7 September 2017

issue

6

1 reference

7 September 2017

page(s)

983-992

1 reference

CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferation

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Another twist in the transforming growth factor beta-induced cell-cycle arrest chronicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Ghrelin attenuates gastrointestinal epithelial damage induced by doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

CXCR3 ligands: redundant, collaborative and antagonistic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Involvement of the PI 3-kinase signaling pathway in progression of colon adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Activated expression of the chemokine Mig after chemotherapy contributes to chemotherapy-induced bone marrow suppression and lethal toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Regulation of CXCL9/10/11 in oral keratinocytes and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Expression and purification of recombinant human Mig in Escherichia coli and its comparison with murine Mig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

mTOR and cancer: insights into a complex relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

TGF-beta: receptors and cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Interactions between the microbiota and the intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury: involvement of mTORC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Evidence for PI3K-dependent CXCR3 agonist-induced degranulation of human cord blood-derived mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Transcriptional and translational regulation of TGF-beta production in response to apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1869-Y

Leptin secretion by white adipose tissue and gastric mucosa

21 January 2018

1 reference

12 December 2020

High glucose regulates cyclin D1/E of human mesenchymal stem cells through TGF-beta1 expression via Ca2+/PKC/MAPKs and PI3K/Akt/mTOR signal pathways

1 reference

12 December 2020

Identification of CRG-2. An interferon-inducible mRNA predicted to encode a murine monokine

1 reference

12 December 2020

CXCL9 attenuated chemotherapy-induced intestinal mucositis by inhibiting proliferation and reducing apoptosis

1 reference

12 December 2020

Suppression of human CD4+ T cell activation by 3,4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10

1 reference

12 December 2020

Chronic antagonism of Mig inhibits cellular infiltration and promotes survival of class II MHC disparate skin allografts

1 reference

12 December 2020

10.1007/S00432-014-1869-Y

Identifiers

DOI

1 reference

7 September 2017

1 reference